solomo.ai

Gayatri BioOrganics Ltd (GAYATRIBI) — shareholding pattern, promoter holding, financials and share price

About Gayatri BioOrganics Ltd (GAYATRIBI)

Gayatri BioOrganics Ltd operates in the Commodity Chemicals industry, within the Chemicals sector. It trades on the NSE as GAYATRIBI and on the BSE under scrip code 524564. Its ISIN is INE052E01015.

Incorporated in 1993, Gayatri Bio-Organics Ltd manufactures Starch, its derivatives and related by-products, and development of customized application for value added starch derivatives.

Gayatri BioOrganics Limited is primarily in the business of manufacturing starch and its derivatives, including sorbitol, with facilities in Karnataka and Telangana.

The company has one of the largest starch and starch derivative manufacturing units in South India bolstered by a wide distribution network across the country.

Listed peers in Commodity Chemicals: Alcokraft Distillery Ltd, Shree Hari Chemicals Export Ltd, Rajgor Castor Derivatives Ltd, Ritesh International Ltd, Shentracon Chemicals Ltd, Standard Surfactants Ltd.

Valuation & Returns

10 Jul 2026
Industry P/E
45.11x
EPS (TTM)
₹-0.14
Book value / share
₹-4.56
ROE
3%
ROCE
-74.43%
ROA
-66.73%
Debt / equity
-1.02x
Dividend yield
0%
52-week range
₹6.87 – ₹20.25

Ratios are computed from filed results and the last recorded price. Not investment advice.

Financial Performance

Mar 2026

In the year ended Mar 2026, Gayatri BioOrganics Ltd (GAYATRIBI) reported net profit of ₹-1.11 crore and earnings per share of ₹-0.14. Figures are standalone, as filed with the exchanges.

In the quarter ended Mar 2026, net profit ₹-0.42 crore (standalone).

Standalone annual results for Gayatri BioOrganics Ltd (GAYATRIBI), Mar 2022 to Mar 2026. Revenue and net profit in ₹ crore; EPS in ₹ per share.
MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue (₹ cr)01.67000
Net profit (₹ cr)-0.5-1.01-0.68-0.73-1.11
EPS (₹)-0.06-0.13-0.09-0.09-0.14
Compound annual growth for Gayatri BioOrganics Ltd (GAYATRIBI). Stock price CAGR is price return and excludes dividends.
Measure1Y
Profit growth-7.35%

Ownership Summary

Jun 2026

As of Jun 2026, promoters hold 21.59% of Gayatri BioOrganics Ltd (GAYATRIBI) (unchanged from the previous quarter), foreign institutional investors (FII) hold 0.01% and domestic institutional investors (DII) hold 0.23%. Market capitalisation was ₹59 crore on 10 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Mar 2001.

Largest disclosed public shareholders in Jun 2026: FURSA MAURITIUS SPV 1 23.48%, MAHMED RAFFE PATTAN 20.21%, KIRAN KUMAR GALI 13.09%, G NIRMALA JYOTHI 9.36%. Only stakes above the 1% disclosure threshold are named in filings.

QuarterPromoterPledgedFIIDIIPublic
Jun 202621.59%-0.01%0.23%78.41%
Mar 202621.59%-0.01%0.65%78.41%
Dec 202521.59%-0.01%0.65%78.41%
Sep 202521.59%-0.01%0.65%78.41%
Jun 202521.59%-0.01%0.65%78.41%
Mar 202521.59%-0.01%0.65%78.41%
Dec 202443.78%-0.01%0.65%56.22%
Sep 202440.62%-0.01%0.65%59.38%
Every quarter since Mar 2001 Filing data, not investment advice.